Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Current Vascular Pharmacology|January 21, 2015
Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and TreatmentGeorgios Daskalopoulos, Artemis Karkanaki, Athanasia Piouka, et al.
Clinical Endocrinology|August 6, 2013
The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndromeDimitrios Panidis, Konstantinos Tziomalos, Efstathios Papadakis, et al.
Langenbeck'S Archives of Surgery|January 19, 2025
Retrospective analysis of criteria for oncological completion surgery of neuroendocrine tumors of the appendixSabine Wächter, Dimitrios Panidis, Moritz Jesinghaus, et al.
American Journal of Obstetrics and Gynecology|January 4, 2006
Creatine phosphokinase in ectopic pregnancy revisited: significant diagnostic value of its MB and MM isoenzyme fractionsIlias Katsikis, David Rousso, Dimitrios Farmakiotis, et al.
Clinical Endocrinology|March 28, 2008
Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)Evanthia Diamanti-Kandarakis, Ilias Katsikis, Christina Piperi, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 27, 2013
Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndromeDimitrios Panidis, Konstantinos Tziomalos, Djuro Macut, et al.
Obesity Facts|May 18, 2011
The phenotypes of polycystic ovary syndrome defined by the 1990 diagnostic criteria are associated with higher serum vaspin levels than the phenotypes introduced by the 2003 criteriaEkaterini Koiou, Konstantinos Dinas, Konstantinos Tziomalos, et al.
Fertility and Sterility|May 3, 2006
Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndromeDimitrios Panidis, David Rousso, George Koliakos, et al.
European Journal of Internal Medicine|October 14, 2008
Plasma visfatin levels in normal weight women with polycystic ovary syndromeDimitrios Panidis, Dimitrios Farmakiotis, David Rousso, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 15, 2012
Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndromeChristos Vosnakis, Neoklis A Georgopoulos, Anastasia K Armeni, et al.
Pageof 10